Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Clinical trial NCT07231419 · RECRUITING
Trial details
- NCT number
- NCT07231419
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-21
- Primary completion
- 2027-04-06
- Enrollment
- 734
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.